Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02788110 · ClinicalTrials.gov registry record · NA

Work of Breathing During Non-invasive Ventilation in Premature Neonates

A NA study of Bronchopulmonary Dysplasia and Respiratory Distress Syndrome, Newborn, sponsored by Arkansas Children's Hospital Research Institute.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT02788110 is a NA study of Bronchopulmonary Dysplasia and Respiratory Distress Syndrome, Newborn that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 15 participants, below the 236-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02788110, a NA study of Bronchopulmonary Dysplasia and Respiratory Distress Syndrome, Newborn, has completed, sponsored by Arkansas Children's Hospital Research Institute.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Background: Non-invasive forms of respiratory support have been developed to manage respiratory distress and failure in premature newborns without exposing them to the risks associated with invasive mechanical ventilation. It has been difficult to synchronize non-invasive ventilation due to the large air leaks, high respiratory rates, and small tidal volumes inherent to this interface and population. Neurally adjusted ventilatory assist (NAVA) is a novel mode of ventilation that uses a functional naso/orogastric tube with embedded electrodes which detect diaphragmatic contractions (called the Edi signal). NAVA uses this Edi signal to synchronize ventilator support to the patient's own respiratory efforts and to support these efforts as needed. Few studies have examined the use of NAVA with non-invasive ventilation (NIV) in preterm neonates. A group at Arkansas Children's Hospital recently completed a study, looking at work of breathing in an animal model comparing NIV NAVA with the unsynchronized nasal intermittent positive pressure (NIPPV) mode currently used at this hospital. They were able to show that work of breathing was lower with NAVA in this model. This study will take what was shown in the animal model and translate this to the bedside. Using respiratory inductance plethysmography to measure thoracoabdominal asynchrony, this study will compare work of breathing during NIPPV versus NIV NAVA in preterm neonates with respiratory insufficiency. Hypothesis: Work of breathing as estimated by the phase angle (θ) using respiratory inductance plethysmography will be decreased with the use of NIV NAVA in comparison to unsynchronized NIPPV in premature neonates with respiratory insufficiency. Methods: Fifteen premature neonates of between 1-2 kilograms' current weight, with gestational age at birth between 24-34 weeks, and receiving non-invasive ventilation will be enrolled in the study after consent is obtained. The infants will be ventilated using NIV NAVA and

Interventions

  • OTHER Noninvasive neurally adjusted ventilatory assist (NIV NAVA)
  • OTHER Nasal intermittent positive pressure ventilation (NIPPV)

Study Locations (1)

Arkansas

  • Arkansas Children's Hospital - Little Rock

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2016-08
Est. Completion 2018-06
Phase NA

What the Registry Record Tells You About NCT02788110

The ClinicalTrials.gov registry entry for NCT02788110 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 236-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (94% lower). The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which Noninvasive neurally adjusted ventilatory assist (NIV NAVA) is the first listed.

NCT02788110 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT02788110 about?

NCT02788110 is a clinical study titled "Work of Breathing During Non-invasive Ventilation in Premature Neonates". Background: Non-invasive forms of respiratory support have been developed to manage respiratory distress and failure in premature newborns without exposing them to the risks associated with invasive mechanical ventilation. It has been difficult to synchronize non-invasive ventilation due to the lar...

What is the current status of trial NCT02788110?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-08. Estimated completion is 2018-06.

What conditions does trial NCT02788110 study?

This clinical trial studies the following conditions: Bronchopulmonary Dysplasia, Respiratory Distress Syndrome, Newborn.

What interventions are being tested in trial NCT02788110?

The interventions under investigation include: Noninvasive neurally adjusted ventilatory assist (NIV NAVA) (OTHER), Nasal intermittent positive pressure ventilation (NIPPV) (OTHER).

Who is sponsoring clinical trial NCT02788110?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02788110 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bronchopulmonary Dysplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.